You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
The impact of an evidence-based, structured, and objective drug assessment approach for formulary inclusion of proton pump inhibitors in qatar
- In: Posters: Hospital Pharmacy Section
- At: Bangkok (Thailand) (2014)
- Type: Poster
- Poster code: POS-HPS001
- By: AL-BADRIYEH, Daoud (College of Pharmacy, Qatar University, Doha, Qatar)
- Co-author(s): Fahey, Michael (Operation Department, Hamad Medical Corporation, Doha, Qatar)
Zaidan, Manal (Pharmacy Department, Hamad Medical Corporation, Doha, Qatar)
Alkhal, Abdullatif (Medicine Department, Hamad Medical Corporation, Doha, Qatar) - Abstract:
Background: No systematic evidence-based drug selection approach exists in Hamad Medical Corporation (HMC) - the main health provider in Qatar, which is creating confusion among practitioners when selecting from a variety of entities in several drug classes. The proton pump inhibitors (PPI) class is a good example of which.
Objective: To develop.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026